Quest Partners LLC Arcturus Therapeutics Holdings Inc. Transaction History
Quest Partners LLC
- $1.02 Trillion
- Q2 2025
A detailed history of Quest Partners LLC transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Quest Partners LLC holds 20,462 shares of ARCT stock, worth $245,134. This represents 0.03% of its overall portfolio holdings.
Number of Shares
20,462
Previous 35,282
42.0%
Holding current value
$245,134
Previous $374 Million
28.75%
% of portfolio
0.03%
Previous 0.04%
Shares
7 transactions
Others Institutions Holding ARCT
# of Institutions
162Shares Held
26.1MCall Options Held
312KPut Options Held
96.5K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$56.2 Million0.11% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$31.7 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.1.93MShares$23.1 Million0.27% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.1.83MShares$22 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.75MShares$21 Million0.0% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $318M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...